Ethics, pharmacy, policy and pediatric cancer experts publish recommendations for managing and preventing drug shortages
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
In a consensus statement published in the journal Pediatrics, the experts say they sought to move away from the current strategy of reaction to shortages once they have occurred and focus instead on prevention. Using the example of shortages of chemotherapy drugs used for treating children with cancer—therapies proven to have high survival rates for the most common childhood cancers—the group developed “a comprehensive blueprint for action” they say is critical for managing and preventing future drug shortages.
“Although our recommendations were developed with pediatric oncology in mind, and serve as a blueprint for preventing children with cancer from lacking access to essential life-saving medications, we believe that they apply more broadly across medicine to include pediatrics and adult medicine in general,” says Yoram Unguru, a pediatric hematologist/oncologist at the Herman and Walter Samuelson Children’s Hospital at Sinai and faculty member at the Johns Hopkins Berman Institute of Bioethics. Unguru, a coauthor of the consensus statement, was the principal organizer of meetings that led to its creation, bringing together representatives from the Food and Drug Administration (FDA), leadership of the Children’s Oncology Group and The American Society of Pediatric Hematology/Oncology, patient advocacy groups, legal scholars and clinicians.
Some recommendations would represent new norms for healthcare practice, including the sharing of scarce drugs between healthcare institutions and not giving preferential access to patients participating in research studies.
“This statement is significant both for the consensus found by such a diverse group of experts, and for being the first to take seriously the ethical rationale to prevent shortages in the first place,” says Matthew DeCamp, a Johns Hopkins professor at the Berman Institute of Bioethics and Division of General Internal Medicine, and lead author of the consensus statement.
Included in the statement’s six recommendations is a call to develop policies that give equal priority to patients regardless of whether they are participants in research. The authors acknowledge this “may be controversial,” due to the sentiment that fairness requires giving research participants high-priority access to drugs because of their contribution to medical knowledge and future patients. However, the statement’s authors explain that “concerns over undue inducement, public perception, and the imperative to use drugs for indications for which evidence of benefit exists outweigh arguments for giving priority access to research participants.”
For each recommendation the statement also includes potential barriers to its implementation. A centralized information source of drug supply information, for instance, faces the risk that such information will encourage hoarding of existing supplies, including so-called “gray market” suppliers that sell scarce drugs for inflated prices. The statement calls for new policies for both reporting and avoiding these markets, though acknowledges the temptation of healthcare providers to use them in a shortage, when their patients are in need.
The Latest on: Shortages of life-saving drugs
via Google News
The Latest on: Shortages of life-saving drugs
- BMC may procure life-saving drugs in Febon January 5, 2020 at 5:53 pm
But they were also facing a shortage, due to which the decision has been taken on a priority basis. “The problem will be solved by the mid-February, as 50 per cent of the life saving drugs will be ...
- EpiPen shortage forces parents to use expired, contaminated drugs to treat childrenon December 3, 2019 at 12:31 pm
Australia faces a critical shortage of child-sized EpiPens, the life-saving devices used to treat people undergoing a severe allergic reaction, prompting the Government to greenlight drugs that have ...
- Letter to the Editor: Make sure shortages of life-saving drugs don't occuron November 26, 2019 at 10:53 pm
Shortage of a drug as critical as vincristine is never acceptable and ... add their voices to this important cause and ensure that no child with cancer lacks life-saving treatments.
- Shortage of life-saving drug leaves immune-deficient patients in 'terrifying' spot: 'no replacement'on November 18, 2019 at 9:35 am
But now, as the mother of four sons aged 16 to 20, she’s been thrown yet another medical curveball: watching three of her boys struggle with a rare immune disorder — and facing a devastating shortage ...
- How Grand Strand hospitals are handling the nationwide drug shortageson November 11, 2019 at 7:37 am
HORRY COUNTY, S.C. (WMBF) - Hospitals across the country are constantly dealing with a shortage of life-saving drugs. For some of those emergency rooms, the lack of supplies are impacting a doctor’s ...
- How families of children with cancer cope with shortages of life-saving drugs: 'It's terrifying'on November 8, 2019 at 3:18 pm
Bray is now the founder of Angels for Change, a nonprofit aiming to stop shortages of life-saving drugs through advocacy and awareness. She tells Yahoo Lifestyle that the Vincristine shortage was ...
- As Life-Saving Childhood Cancer Drugs Run Short, Patients and Doctors Face Impossible Choiceson November 8, 2019 at 11:12 am
The Hayes family, from Wayne, Pennsylvania, experienced first-hand a problem that doctors say is too common and worsening: shortages of childhood cancer drugs, exacerbated by the dwindling number of ...
- U.S. Hospitals, FDA Grapple With Shortages of Life-Saving Drugson November 2, 2019 at 7:03 am
More than two dozen doctors, nurses, pharmacists, tech specialists and others gathered around a conference table, a "war room" of sorts, to address the shortage of a crucial drug: the blood-thinner ...
- Texas hospitals scramble to cope with shortage of pediatric cancer drugon October 26, 2019 at 9:14 am
“While it is clear that the immediate concern and goal is to solve the issue surrounding vincristine, I believe the community should consider advocacy steps to help prevent future shortages of ...
- Cancer centers scramble amid shortage of ‘essential drug’ used to treat childrenon October 16, 2019 at 5:00 pm
Federal drug officials said Pfizer would be stepping up production by the end of October but supply chain gaps could prolong the shortage to the end of the year. The nonprofit Children's Oncology ...
via Bing News